| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |